Icon ArrowBack
Bio Usawa CEO Menghis Bairu, MD Delivers Seminar at Stanford Medical School’s Center for Innovation and Global Health

May 22, 2025 Kigali, Rwanda and San Francisco, USA

We at Bio Usawa share a passion for health justice and access to lifesaving, affordable biotherapeutics for patients in Africa and beyond. And our passion clearly resonates with key audiences across the healthcare spectrum, including faculty and students at Stanford University Medical School’s Center for Innovation in Global Health (see photo) where today I had the privilege to deliver a presentation on the rapid progress the company has made just in a few short months. Our fast-paced and can-do culture demands that we bring on key personnel to continue on our path.

Learn more about our company and hiring needs here:
https://www.biousawa.com/careers

About Bio Usawa, Inc. (BUI)

Bio Usawa has a singular mission: to manufacture and commercialize high-quality, effective and affordable biosimilars for patients in Africa. We are applying our 100+ years of combined experience in the industry in partnership with governments, agencies, educators and health professionals to make transformative biomedicines in Africa, by Africans, for Africans and beyond. 

Click here to learn more about our company's recent successes and download our new White Paper on Regulatory Approaches to Biosimilars in Africa.